Huapont Life Sciences Co Ltd (002004) — Cash Flow Reinvestment Rate
Huapont Life Sciences Co Ltd (002004) has a Cash Flow Reinvestment Rate of 0.25x as of September 2025, reinvesting CN¥160.05 Million (capex CN¥160.05 Million ) from operating cash flow of CN¥635.17 Million. See Huapont Life Sciences Co Ltd (002004) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Huapont Life Sciences Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Huapont Life Sciences Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see how efficiently does Huapont Life Sciences Co Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Huapont Life Sciences Co Ltd. See 002004 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥1.32 Billion | CN¥2.10 Billion | CN¥638.28 Million | ▼ -15.1% |
| 2024 | 0.74x | CN¥1.20 Billion | CN¥1.63 Billion | CN¥956.27 Million | ▼ -21.3% |
| 2023 | 0.94x | CN¥1.50 Billion | CN¥1.59 Billion | CN¥1.28 Billion | ▲ +32.0% |
| 2022 | 0.71x | CN¥1.72 Billion | CN¥2.41 Billion | CN¥1.13 Billion | ▼ -41.9% |
| 2021 | 1.23x | CN¥1.56 Billion | CN¥1.27 Billion | CN¥1.26 Billion | ▲ +51.9% |
| 2020 | 0.81x | CN¥1.92 Billion | CN¥2.37 Billion | CN¥1.23 Billion | ▲ +1.2% |
| 2019 | 0.80x | CN¥1.66 Billion | CN¥2.08 Billion | CN¥1.43 Billion | ▲ +1.1% |
| 2018 | 0.79x | CN¥1.51 Billion | CN¥1.91 Billion | CN¥1.10 Billion | ▼ -53.9% |
| 2017 | 1.71x | CN¥1.01 Billion | CN¥591.40 Million | CN¥972.67 Million | ▼ -76.2% |
| 2016 | 7.18x | CN¥3.68 Billion | CN¥511.90 Million | CN¥651.24 Million | ▲ +189.1% |
| 2015 | 2.48x | CN¥850.93 Million | CN¥342.45 Million | CN¥831.76 Million | ▲ +93.5% |
| 2014 | 1.28x | CN¥585.54 Million | CN¥455.96 Million | CN¥585.54 Million | ▲ +18.2% |
| 2013 | 1.09x | CN¥379.81 Million | CN¥349.51 Million | CN¥379.81 Million | ▼ -11.1% |
| 2012 | 1.22x | CN¥315.21 Million | CN¥257.75 Million | CN¥315.21 Million | ▲ +72.7% |
| 2011 | 0.71x | CN¥95.77 Million | CN¥135.23 Million | CN¥95.77 Million | ▼ -0.6% |
| 2010 | 0.71x | CN¥56.87 Million | CN¥79.84 Million | CN¥56.87 Million | ▲ +19.8% |
| 2009 | 0.59x | CN¥73.46 Million | CN¥123.53 Million | CN¥73.46 Million | ▼ -26.9% |
| 2008 | 0.81x | CN¥92.49 Million | CN¥113.76 Million | CN¥92.49 Million | ▼ -48.1% |
| 2007 | 1.57x | CN¥124.02 Million | CN¥79.21 Million | CN¥124.02 Million | ▲ +116.7% |
| 2006 | 0.72x | CN¥47.76 Million | CN¥66.10 Million | CN¥47.76 Million | ▼ -28.9% |
| 2005 | 1.02x | CN¥44.42 Million | CN¥43.69 Million | CN¥44.42 Million | ▲ +167.6% |
| 2004 | 0.38x | CN¥26.83 Million | CN¥70.60 Million | CN¥26.83 Million | ▼ -30.1% |
| 2003 | 0.54x | CN¥30.82 Million | CN¥56.68 Million | CN¥30.82 Million | ▼ -62.0% |
| 2002 | 1.43x | CN¥52.71 Million | CN¥36.88 Million | CN¥52.71 Million | — |